GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.98 $7.70 Thursday, 18th Apr 2024 FATE stock ended at $5.04. This is 4.36% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.33% from a day low at $4.98 to a day high of $5.35.
90 days $4.10 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2021-01-06 $87.50 $100.45 $87.01 $99.78 3 389 554
2021-01-05 $86.00 $91.29 $84.17 $86.72 974 811
2021-01-04 $91.54 $93.20 $88.58 $89.68 1 057 943
2020-12-31 $93.77 $94.32 $88.29 $90.93 663 393
2020-12-30 $93.08 $96.40 $93.08 $93.62 667 611
2020-12-29 $96.00 $97.63 $88.33 $92.59 762 975
2020-12-28 $101.80 $101.86 $96.11 $96.21 671 468
2020-12-24 $100.53 $102.33 $98.62 $99.50 200 319
2020-12-23 $100.97 $101.86 $95.91 $100.80 869 715
2020-12-22 $98.10 $102.25 $94.77 $100.95 918 917
2020-12-21 $93.26 $94.09 $91.02 $94.06 1 595 685
2020-12-18 $93.00 $95.22 $90.96 $93.27 2 616 075
2020-12-17 $92.55 $93.58 $90.08 $92.25 996 945
2020-12-16 $93.10 $94.03 $90.00 $92.07 1 070 891
2020-12-15 $97.31 $98.06 $90.00 $92.77 877 503
2020-12-14 $95.96 $103.66 $95.23 $96.38 1 270 681
2020-12-11 $95.70 $96.93 $92.12 $94.74 1 409 230
2020-12-10 $86.09 $97.27 $86.01 $96.85 1 700 113
2020-12-09 $91.53 $93.00 $84.65 $86.60 2 106 073
2020-12-08 $84.70 $96.00 $82.55 $91.60 6 106 127
2020-12-07 $68.48 $89.92 $68.17 $83.77 6 423 311
2020-12-04 $60.71 $62.50 $60.39 $60.79 515 835
2020-12-03 $60.94 $61.72 $59.33 $60.42 907 908
2020-12-02 $59.88 $61.35 $58.75 $60.53 871 236
2020-12-01 $58.84 $60.68 $57.50 $60.22 1 372 912
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT